Corcept Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CORT

Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. 

CEO
Joseph K. Belanoff
CEOJoseph K. Belanoff
Employees
730
Employees730
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
1998
Founded1998
Employees
730
Employees730

CORT Key Statistics

Market cap
12.81B
Market cap12.81B
Price-Earnings ratio
279.84
Price-Earnings ratio279.84
Dividend yield
Dividend yield
Average volume
827.33K
Average volume827.33K
High today
$119.95
High today$119.95
Low today
$116.60
Low today$116.60
Open price
$116.60
Open price$116.60
Volume
236.87K
Volume236.87K
52 Week high
$122.21
52 Week high$122.21
52 Week low
$28.66
52 Week low$28.66

Stock Snapshot

As of today, Corcept Therapeutics(CORT) shares are valued at $118.47. The company's market cap stands at 12.81B, with a P/E ratio of 279.84.

As of 2026-08-18, Corcept Therapeutics(CORT) stock has fluctuated between $116.60 and $119.95. The current price stands at $118.47, placing the stock +1.6% above today's low and -1.2% off the high.

Corcept Therapeutics(CORT) shares are trading with a volume of 236.87K, against a daily average of 827.33K.

During the past year, Corcept Therapeutics(CORT) stock moved between $28.66 at its lowest and $122.21 at its peak.

During the past year, Corcept Therapeutics(CORT) stock moved between $28.66 at its lowest and $122.21 at its peak.

CORT News

TipRanks 5h
Corcept Therapeutics assumed with a Buy at Truist

Truist assumed coverage of Corcept Therapeutics (CORT) with a Buy rating with a price target of $164, up from $50. The form is positive on the company’s opportu...

TipRanks 16h
Corcept Therapeutics Earnings Call Signals Accelerating Growth

Corcept Therapeutics ((CORT)) has held its Q2 earnings call. Read on for the main highlights of the call. Summer Sale - Claim 70% Off TipRanks Unlock powerful i...

Simply Wall St 1d
Corcept Therapeutics Stock Looks Discounted On Sales But Premium Priced On Broader Checks

Corcept Therapeutics stock has delivered a 447.7% return over the past 5 years, yet broader valuation checks suggest the shares are not a straightforward bargai...

Corcept Therapeutics Stock Looks Discounted On Sales But Premium Priced On Broader Checks

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
14.3%
Sell
14.3%

People also own

Based on the portfolios of people who own CORT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.